Creative Planning Volitionrx LTD Transaction History
Creative Planning
- $129 Billion
- Q3 2025
A detailed history of Creative Planning transactions in Volitionrx LTD stock. As of the latest transaction made, Creative Planning holds 10,056 shares of VNRX stock, worth $3,318. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,056
Previous 10,056
-0.0%
Holding current value
$3,318
Previous $7,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding VNRX
# of Institutions
32Shares Held
26.3MCall Options Held
0Put Options Held
0-
Lagoda Investment Management, L.P. New York, NY12.5MShares$4.12 Million4.96% of portfolio
-
Armistice Capital, LLC New York, NY9.38MShares$3.1 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.53MShares$504,9150.0% of portfolio
-
Geode Capital Management, LLC Boston, MA878KShares$289,7960.0% of portfolio
-
Black Rock Inc. New York, NY516KShares$170,3040.0% of portfolio
About VOLITIONRX LTD
- Ticker VNRX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 57,297,000
- Market Cap $18.9M
- Description
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...